Recent MYNZ News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/21/2024 12:15:22 PM
- Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 10/21/2024 12:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/18/2024 08:00:40 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/09/2024 09:20:02 PM
- Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version • GlobeNewswire Inc. • 10/08/2024 12:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/03/2024 09:11:40 PM
- Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 • GlobeNewswire Inc. • 10/01/2024 12:01:00 PM
- Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador • GlobeNewswire Inc. • 09/18/2024 12:01:00 PM
- Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert • GlobeNewswire Inc. • 09/04/2024 08:01:00 AM
- Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience • GlobeNewswire Inc. • 07/25/2024 12:01:00 PM
- Micro Cap Bid Up Following FDA Submission Announcement • AllPennyStocks.com • 07/09/2024 01:30:00 PM
- Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test • GlobeNewswire Inc. • 07/09/2024 07:01:00 AM
- Mainz Biomed Provides Half Year 2024 Corporate Update • GlobeNewswire Inc. • 07/02/2024 12:01:00 PM
- Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 • GlobeNewswire Inc. • 06/03/2024 12:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/31/2024 09:01:03 PM
- Mainz Biomed Reports Results of 2024 Annual General Meeting • GlobeNewswire Inc. • 05/31/2024 09:01:00 PM
- Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting • GlobeNewswire Inc. • 05/28/2024 12:01:00 PM
- Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial • GlobeNewswire Inc. • 05/20/2024 12:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:20:09 PM
- Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. • GlobeNewswire Inc. • 05/07/2024 12:01:00 PM
- Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic • GlobeNewswire Inc. • 04/25/2024 01:29:00 PM
- Mainz Biomed Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/09/2024 12:01:00 PM
- Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment • GlobeNewswire Inc. • 03/19/2024 12:01:00 PM
- Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options • GlobeNewswire Inc. • 03/18/2024 12:01:00 PM
- Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations • GlobeNewswire Inc. • 03/12/2024 12:01:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM